ID

36208

Beschrijving

Study ID: 101963 Clinical Study ID: SCA101963 Study Title: A randomised, blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and risperidone in healthy, non-smoking, male volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: lamotrigine Trade Name: Lamictal XR,Lamictal,LAMICTIN Study Indication: Schizophrenia

Trefwoorden

Versies (1)
  1. 22-04-19 22-04-19 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

22 april 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Potential Pharmacokinetic Interaction between Lamotrigine and Risperidone; 101963

Engels

Investigational Product Discontinuation

1 Formulieren  
Administrative Data
Beschrijving

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Beschrijving

Clinical Trial Subject Unique Identifier

Datatype

integer

Alias
UMLS CUI [1]
C2348585
Investigational Product Discontinuation
Beschrijving

Investigational Product Discontinuation

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0457454
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Beschrijving

Experimental drug, Discontinuation, Permanent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0205355
If Yes, tick the primary reason the investigational product was stopped
Beschrijving

Experimental drug, Discontinuation, Permanent, Indication

Datatype

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0205355
UMLS CUI [1,4]
C4288399
UMLS CUI [1,5]
C0392360
Terug naar het begin van de pagina

Similar models

Investigational Product Discontinuation

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Clinical Trial Subject Unique Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
Investigational Product Discontinuation
C0304229 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Experimental drug, Discontinuation, Permanent
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
boolean
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,3])
Item
If Yes, tick the primary reason the investigational product was stopped
text
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,3])
C4288399 (UMLS CUI [1,4])
C0392360 (UMLS CUI [1,5])
Experimental drug, Discontinuation, Permanent, Indication
Code List
If Yes, tick the primary reason the investigational product was stopped
CL Item
Adverse event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study [6] D Sponsor terminated study (4)
CL Item
Other (5)
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial